X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Photo by Carmen Natale/ALM.  Front row, left to right: Ryan L. Bergeron, April M. Capati, Roy H. Wepner, William L. Mentlik, Jonathan A. David, Elizabeth Lafferty, Paul H. Kochanski. Back row, left to right: Gregg A. Paradise, Natalie S. Richer, Orville R. Cockings, Robert B. Hander, Alexander Solo, Gregory S. Gewirtz, Stephen F. Roth, Aaron S. Eckenthal

As an intellectual property boutique, it’s not unusual for Lerner, David, Littenberg, Krumholz & Mentlik to handle numerous complex and high-stakes IP disputes over the course of a year, and that remained true in 2017. Aside from successfully representing New York University in a research and license agreement dispute with Pfizer, the firm’s litigators successfully represented clients on both sides of patent-review proceedings: Lerner David prevailed at the Federal Circuit defending generic drugmaker Dr. Reddy’s Laboratories, and at the trial court level won invalidation on behalf of Amneal, another generic drugmaker.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to Lexis Advance®.

Not a Lexis Advance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

David Gialanella

David Gialanella, Bureau Chief, has been with the New Jersey Law Journal since 2010, covering business of law, litigation, legislation and various other topics. In his current role, he is responsible for the Law Journal's print and web products. Reach him at dgialanella@alm.com.

More from this author

 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.